Tous Actualités
Suivre
Abonner curasan AG

curasan AG

euro adhoc: curasan AG
Half-yearly Report
Announcement according to articles 37v ff. WpHG [Securities Trading Act] with the aim of a Europe-wide distribution

  Tip announcement for financial statements transmitted by euro adhoc. The
  issuer is responsible for the content of this announcement.
The financial statement is available:
in the internet at: http://www.curasan.de/com/investor_relations/quarterly_reports.php
in the internet on:    10.08.2007
end of announcement                               euro adhoc 26.07.2007 10:51:45

Further inquiry note:

Branche: Biotechnology
ISIN: DE0005494538
WKN: 549453
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse Hannover / free trade
Börse München / free trade

Plus de actualités: curasan AG
Plus de actualités: curasan AG
  • 14.06.2007 – 14:33

    euro adhoc: curasan AG / Director's Dealings

    Notification concerning transactions by persons discharging managerial responsibilities pursuant to section 15a of the WpHG, transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. 14.06.2007 Xetra (euro adhoc) - Details of the person subject to the disclosure requirement: Name: Hans Dieter Rössler Name of ...

  • 14.06.2007 – 09:27

    curasan AG: REVOIS® All-in-One Dental Implant System Registered in the U.S.

    ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. new product Kleinostheim (euro adhoc) - curasan AG, a German leader in regenerative medicine, has obtained FDA clearance for its REVOIS® All-in-One dental implant system, permitting the sale of the system in the U.S. This means that the system can be ...

  • 12.06.2007 – 16:27

    euro adhoc: other / curasan: US-Registration for REVOIS® Dental Implant System

    Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Marketing 12.06.2007 curasan AG (ISIN DE 000 549 453 8) listed in the Prime Standard obtained the FDA-certification for her REVOIS® dental implant system. By this, the medical product is registered for distribution in the United States of ...